Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 97 publications
The frequent exacerbator phenotype in bronchiectasis revisited: Data from EMBARC registry.
Journal: American journal of respiratory and critical care medicine
Published: April 01, 2026
Resource impact of bronchiectasis and associated exacerbations: based on a 5-year prospective observational cohort study (BronchUK).
Journal: BMJ open respiratory research
Published: March 06, 2026
A pragmatic, multicentre, placebo-controlled, 3-arm, double-blinded, randomised controlled trial, incorporating an internal pilot, to determine the role of bronchodilators in preventing exacerbations of bronchiectasis.
Journal: Health technology assessment (Winchester, England)
Published: February 09, 2026
Taking a wider view: The Lancet Respiratory Medicine Commission on bronchiectasis.
Journal: The Lancet. Respiratory medicine
Published: January 11, 2026
Mucoactive therapies and the European Respiratory Society guideline for adult bronchiectasis: what now after the CLEAR trial?
Journal: The European respiratory journal
Published: January 03, 2026
Comorbid diabetes disease severity and microbial changes in patients with bronchiectasis: a combined analysis of data from the EMBARC, EMBARC-India, Australian, and BE-China registries.
Journal: The Lancet. Respiratory medicine
Published: December 23, 2025
Assessment of a bacterial quantification assay to detect and monitor Pseudomonas aeruginosa infection in patients with bronchiectasis.
Journal: ERJ open research
Published: October 08, 2025
Upper-Airway Microbiome, Mucociliary Function, and Clinical Outcomes in Bronchiectasis: Data from the EMBARC-BRIDGE Study.
Journal: American journal of respiratory and critical care medicine
Published: September 12, 2025
Endotypes of Pseudomonas aeruginosa Infection in Bronchiectasis Are Associated with Inhaled Antibiotic Response: Results from Two Randomized, Double-Blind, Placebo-controlled Phase III Trials (ORBIT 3 and ORBIT 4).
Journal: American journal of respiratory and critical care medicine
Published: July 15, 2025
The CFTR potentiator icenticaftor for treatment of bronchiectasis: an international phase 2, double-blind, randomized placebo-controlled trial.
Journal: American journal of respiratory and critical care medicine
Published: June 30, 2025
European Respiratory Society clinical practice guideline for the management of adult bronchiectasis.
European Respiratory Society clinical practice guideline for the management of adult bronchiectasis.
Journal: The European respiratory journal
Published: June 02, 2025
Last Updated: 09/26/2026